A C.D.C. panel recommends J.&J. shots restart with a label noting the risk of very rare blood clots.

Health
By BY CARL ZIMMER AND EMILY ANTHES from NYT Health https://ift.tt/3tOAeRZ
via IFTTT internal-essential, Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Labeling and Labels (Product) The U.S. government is likely to follow the panel’s recommendation and end the pause.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda